Economic Consequences of an Implanted Neuroprosthesis in Subjects with Spinal Cord Injury for Restoration of an Effective Cough.

Objective: To determine if an implanted neuroprosthesis for restoration of an effective cough is less costly than conventional methods of respiratory management. Methods: Nonrandomized clinical trial of participants ( N = 14) with spinal cord injury (SCI) using the Cough Stimulator device in the inp...

Descripción completa

Detalles Bibliográficos
Publicado en:Topics in Spinal Cord Injury Rehabilitation Vol. 23; no. 3; pp. 271 - 279
Autores principales: DiMarco, Anthony F., Geertman, Robert T., Tabbaa, Kutaiba, Polito, Rebecca R., Kowalski, Krzysztof E.
Formato: clinical trial research tables/charts Journal Article
Publicado: KnowledgeWorks Global, Ltd Summer2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124654492&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 124654492
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10820744
        0OF
      jtl: Topics in Spinal Cord Injury Rehabilitation
      issn: 10820744
      maglogo: N
    pubinfo:
      dt: Summer2017
      vid: 23
      iid: 3
      pid: 81084
      pub: KnowledgeWorks Global, Ltd
      place: Richmond, Virginia
    artinfo:
      ui:
        124654492
        124654492
        124654492
        10.1310/sci2303-271
        124654492
      ppf: 271
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Economic Consequences of an Implanted Neuroprosthesis in Subjects with Spinal Cord Injury for Restoration of an Effective Cough.
      aug:
        au:
          DiMarco, Anthony F.
          Geertman, Robert T.
          Tabbaa, Kutaiba
          Polito, Rebecca R.
          Kowalski, Krzysztof E.
        affil: Department of Physical Medicine and Rehabilitation, Case Western Reserve University
      sug:
        subj:
          Myoelectric Prosthesis Economics
          Spinal Cord Injuries Complications
          Cough
          Electric Stimulation Equipment and Supplies
          Respiratory Tract Diseases Prevention and Control
          Respiratory Tract Diseases Epidemiology
          United States
          Hospitals
          After Care
          Inpatients
          Outpatients
          Human
          Female
          Male
          Child
          Adolescence
          Adult
          Middle Age
          Pretest-Posttest Design
          T-Tests
          Post Hoc Analysis
          P-Value
          Clinical Trials
          Descriptive Statistics
          Data Analysis Software
          Funding Source
          Child: 6-12 years
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objective: To determine if an implanted neuroprosthesis for restoration of an effective cough is less costly than conventional methods of respiratory management. Methods: Nonrandomized clinical trial of participants ( N = 14) with spinal cord injury (SCI) using the Cough Stimulator device in the inpatient hospital setting for Cough Stimulator implantation and outpatient hospital or residence for follow-up. A neuroprosthesis was implanted for restoration of an effective cough. The annual costs associated with respiratory management, without (pre implantation) and with (post implantation) the neuroprosthesis, were examined over a 4-year period. Results: The total cost related to implantation of the Cough Stimulator was $59,891, with no maintenance costs over subsequent years. The incidence of respiratory tract infections and the need for caregiver support fell significantly following implantation. The costs associated with respiratory tract infections fell significantly from a mean of $36,406 ± 11,855/year to $13,284 ± 7,035/year ( p < .05) pre and post implantation, respectively. Costs fell further to $8,817 ± 5,990 and $4,467 ± 4,404 following the 2nd and 3rd years post implantation ( p < .05), respectively. The costs associated with caregiver support fell significantly from $25,312 ± 8,019/year to $2,630 ± 2,233/year ( p < .05) pre and post implantation, respectively, and remained low in subsequent years ( p < .05). Other costs related to secretion management fell significantly and remained low in subsequent years ( p < .05). Break-even analysis demonstrated that this point was reached in the first year. Conclusion: The results of this investigation demonstrate that implantation and use of the Cough Stimulator resulted in significant reductions in the overall costs of respiratory management in this patient population.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N